Evidence map›Paper›PMID 29160867›Full record

ArticleScientific data2017

Protocols and characterization data for 2D, 3D, and slice-based tumor models from the PREDECT project.

Ronald de Hoogt, Marta F Estrada, Suzana Vidic, Emma J Davies, Annika Osswald, Michael Barbier, Vítor E Santo, Kjersti Gjerde, Hanneke J A A van Zoggel, Sami Blom and 11 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Microfluidic Modulation of Microvasculature in Microdissected Tumors.bioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Article
  5. Making In Vitro Tumor Models Whole Again.Advanced healthcare materials · 2023
    Review
  6. Fabrication and Characterization Techniques of In Vitro 3D Tissue Models.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ronald de HoogtJanssen Pharmaceutica N.V., Turnhoutseweg 30, Beerse 2340, Belgium.
Marta F EstradaiBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras 2780-901, Portugal.
Suzana VidicInstitute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana SI-1000, Slovenia.
Emma J DaviesOncology IMED, Bioscience, AstraZeneca, 1 Francis Crick Avenue, Cambridge CB2 0AA, UK.
Annika OsswaldBoehringer Ingelheim RCV, GmbH & Co. KG, Dr. Boehringer-Gasse 5-11, Vienna 1120, Austria.
Michael BarbierUniversity of Antwerp, Department of Veterinary Sciences, Laboratory of Cell Biology & Histology, Universiteitsplein 1, Wilrijk 2610, Belgium.
Vítor E SantoiBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras 2780-901, Portugal.
Kjersti GjerdeJanssen Pharmaceutica N.V., Turnhoutseweg 30, Beerse 2340, Belgium.
Hanneke J A A van ZoggelERASMUS MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Sami BlomInstitute for Molecular Medicine Finland (FIMM), Tukholmankatu 8, University of Helsinki, 00014, Finland.ORCID 0000-0002-1878-8911
Meng DongDr Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Auerbachstrasse 112, Stuttgart 70376, Germany.
Katja NärhiInstitute for Molecular Medicine Finland (FIMM), Tukholmankatu 8, University of Helsinki, 00014, Finland.
Erwin BoghaertAbbVie, 1 North Waukegan Road, North Chicago, IL 60064-6098, USA.
Catarina BritoiBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, Oeiras 2780-901, Portugal.ORCID 0000-0002-8926-279X
Yolanda ChongJanssen Pharmaceutica N.V., Turnhoutseweg 30, Beerse 2340, Belgium.
Wolfgang SommergruberBoehringer Ingelheim RCV, GmbH & Co. KG, Dr. Boehringer-Gasse 5-11, Vienna 1120, Austria.
Heiko van der KuipDr Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Auerbachstrasse 112, Stuttgart 70376, Germany.
Wytske M van WeerdenERASMUS MC, Wytemaweg 80, Rotterdam 3015 CN, The Netherlands.
Emmy W VerschurenInstitute for Molecular Medicine Finland (FIMM), Tukholmankatu 8, University of Helsinki, 00014, Finland.ORCID 0000-0001-5771-9129
John HickmanInstitut de Recherches Servier c/o 126 boulevard Pereire, Paris 75017, France.
Ralph GraeserBoehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach an der Riß 88400, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional (2D) culture of cancer cells in vitro does not recapitulate the three-dimensional (3D) architecture, heterogeneity and complexity of human tumors. More representative models are required that better reflect key aspects of tumor biology. These are essential studies of cancer biology and immunology as well as for target validation and drug discovery. The Innovative Medicines Initiative (IMI) consortium PREDECT (www.predect.eu) characterized in vitro models of three solid tumor types with the goal to capture elements of tumor complexity and heterogeneity. 2D culture and 3D mono- and stromal co-cultures of increasing complexity, and precision-cut tumor slice models were established. Robust protocols for the generation of these platforms are described. Tissue microarrays were prepared from all the models, permitting immunohistochemical analysis of individual cells, capturing heterogeneity. 3D cultures were also characterized using image analysis. Detailed step-by-step protocols, exemplary datasets from the 2D, 3D, and slice models, and refined analytical methods were established and are presented.

Indexed as

Models, BiologicalNeoplasmsCell Culture TechniquesHumansImaging, Three-Dimensional

Identifiers

PMID29160867
PMCPMC5697359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.